Close
Show

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities

Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810